Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIMDWNASDAQ:BBLGWOTCMKTS:CHEOFOTCMKTS:CLLKF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIMDWAinos$0.10-5.9%$0.11$0.03▼$0.37N/AN/A20,087 shs1,700 shsBBLGWBone Biologics$16.90-16.3%$20.21$3.00▼$95.04N/AN/A2,106 shs200 shsCHEOFCochlear$177.28$166.63$148.62▼$237.38N/AN/A125 shsN/ACLLKFBICO Group AB (publ)C$3.87C$3.59C$2.59▼C$5.60N/AN/A2,030 shsN/A7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIMDWAinos0.00%-5.88%-6.82%-33.66%+29.75%BBLGWBone Biologics0.00%0.00%-16.34%-78.33%-29.29%CHEOFCochlear0.00%0.00%+9.96%-13.76%-14.77%CLLKFBICO Group AB (publ)0.00%+4.59%+26.89%+26.89%-10.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIMDWAinosN/AN/AN/AN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/AN/AN/ACHEOFCochlear0.0907 of 5 stars0.02.00.80.00.60.00.0CLLKFBICO Group AB (publ)N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIMDWAinos 0.00N/AN/AN/ABBLGWBone Biologics 0.00N/AN/AN/ACHEOFCochlear 0.00N/AN/AN/ACLLKFBICO Group AB (publ) 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIMDWAinos$20.73KN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/ACHEOFCochlearN/AN/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIMDWAinosN/AN/A0.00∞N/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/A0.00∞N/AN/AN/AN/AN/ACHEOFCochlearN/A$1.64107.97∞N/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIMDWAinosN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/ACHEOFCochlear$1.270.72%N/A77.34%N/ACLLKFBICO Group AB (publ)N/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ACHEOFCochlear22.47%CLLKFBICO Group AB (publ)N/AInsider OwnershipCompanyInsider OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ACHEOFCochlearN/ACLLKFBICO Group AB (publ)N/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIMDWAinos40N/AN/ANot OptionableBBLGWBone Biologics2N/AN/ANot OptionableCHEOFCochlear4,800N/AN/ANot OptionableCLLKFBICO Group AB (publ)880N/AN/ANot OptionableCHEOF, AIMDW, CLLKF, and BBLGW HeadlinesRecent News About These CompaniesBICO Group AB (publ) (CLLKF) Q1 2025 Earnings Call TranscriptApril 30 at 12:02 AM | seekingalpha.comBICO sees 12% EBITDA margin improvement in Q4 2024, outlines strategic focus on lab automation and recurring revenuesFebruary 19, 2025 | msn.comBICO Group AB (CLLKF) Q4 2024 Earnings Call TranscriptFebruary 19, 2025 | seekingalpha.comBICO Group Reports Q3 2024 Financial Performance Amid Market ChallengesNovember 27, 2024 | markets.businessinsider.comBICO Group AB (CLLKF) Q3 2024 Earnings Call TranscriptNovember 26, 2024 | seekingalpha.comBICO Group AB (publ) (BCCOY)November 5, 2024 | finance.yahoo.comBICO Group AB Class BNovember 5, 2024 | morningstar.comBICO Group AB (publ) (CLLKF) Q2 2024 Earnings Call TranscriptAugust 21, 2024 | seekingalpha.comGN Store Nord A/S (GNN0.DU)August 13, 2024 | finance.yahoo.comThe 3 Best 3D Bioprinting Stocks to Buy NowJuly 26, 2024 | investorplace.comBICO Group AB (publ) (CLLKF)July 23, 2024 | nz.finance.yahoo.com3 3D Printing Stocks With the Potential to Make You an Overnight MillionaireApril 30, 2024 | investorplace.comBICO: Too Many UnknownsFebruary 8, 2024 | seekingalpha.comBICO Group AB Class B BICONovember 13, 2023 | morningstar.comInvestment approvals to hit P1T in Oct – BoIOctober 25, 2023 | msn.comBICO Group AB (publ) reports Q1 resultsMay 4, 2023 | msn.comNotice to attend the Annual General Meeting in BICO Group AB (publ)April 6, 2023 | privataaffarer.seCLLKF BICO Group AB (publ)February 22, 2023 | seekingalpha.comBICO Group AB (publ) (BICO.ST)February 16, 2023 | finance.yahoo.comBICO Group AB (publ) (CLLKF) Q3 2022 Earnings Call TranscriptNovember 12, 2022 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCHEOF, AIMDW, CLLKF, and BBLGW Company DescriptionsAinos NASDAQ:AIMDW$0.10 -0.01 (-5.88%) As of 04/28/2025Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.Bone Biologics NASDAQ:BBLGW$16.90 -3.30 (-16.34%) As of 04/29/2025Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.Cochlear OTCMKTS:CHEOF$177.28 0.00 (0.00%) As of 04/29/2025Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.BICO Group AB (publ) OTCMKTS:CLLKFC$3.87 0.00 (0.00%) As of 04/29/2025BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end products and services in precision dispensing, advanced sample preparation, multiplex analysis and assay miniaturization, diagnostic and medical device manufacturing for life science and diagnostic industries. It primarily serves medical, pharmaceutical, and cosmetic industries. The company offers its products through sales organizations, as well as through an extensive distributor network. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was incorporated in 2016 and is headquartered in Gothenburg, Sweden. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hims & Hers Stock Soars on Novo Nordisk Collaboration 3 Dividend Kings Outshining the Market in 2025 Tesla's Band-Aid Has Been Ripped Off: Rally Mode Engaged Amazon's Earnings Will Make or Break the Stock's Comeback Why D-Wave's Project With Davidson Is a Game-Changer For Quantum NXP Semiconductors: A Buy-and-Hold Stock in the Buy Zone Joby Aviation Shares Eye Breakout After Transition Flight Win Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
